Intravitreal bevacizumab for subfoveal choroidal neovascularization secondary to age-related macular degeneration in an Indian population

Abstract

To investigate the 6-month safety profile and clinical outcomes of intravitreal bevacizumab for treating subfoveal choroidal neovascularization (CNV) in age-related macular degeneration (AMD). We performed a prospective nonrandomized interventional study of 40 consecutive patients (40 eyes) with subfoveal CNV due to AMD. Patients underwent standard… (More)
DOI: 10.1007/s10384-007-0496-4

Topics

6 Figures and Tables

Cite this paper

@article{Azad2007IntravitrealBF, title={Intravitreal bevacizumab for subfoveal choroidal neovascularization secondary to age-related macular degeneration in an Indian population}, author={Raj Vardhan Azad and Mansur Ali Khan and Bhuvan Chanana and Shorya Vardhan Azad}, journal={Japanese Journal of Ophthalmology}, year={2007}, volume={52}, pages={52-56} }